Results 91 to 100 of about 4,644 (117)
Genotype-Phenotype Relations for the Dystonia-Parkinsonism Genes <i>GLB1</i>, <i>SLC6A3</i>, <i>SLC30A10</i>, <i>SLC39A14</i>, and <i>PLA2G6</i>: MDSGene Systematic Review. [PDF]
Int J Mol SciRodriguez-Antiguedad J, Rajalingam R, Krüger C, Teixeira-Dos-Santos D, Sun C, Fernandez-Toledo E, Duarte A, Saffie-Awad P, Barrett MJ, Flanigan JL, Emamikhah M, Patel N, San Luciano M, Cooper C, Bahr N, Oguh O, Buhrmann A, Vater M, Fuchshofen R, Vulinovic F, Parreidt MI, Weissbach A, Lohmann K, Klein C, Marras C, Camargos S. +25 moreeuropepmc +1 more sourceValue contribution of blood-based neurofilament light chain as a biomarker in multiple sclerosis using multi-criteria decision analysis. [PDF]
Front Public HealthMonreal E, Ruiz PD, San Román IL, Rodríguez-Antigüedad A, Moya-Molina MÁ, Álvarez A, García-Arcelay E, Maurino J, Shepherd J, Cabrera ÁP, Villar LM. +10 moreeuropepmc +1 more sourceEconomic burden of secondary progressive multiple sclerosis: DISCOVER study. [PDF]
BMC Health Serv ResOreja-Guevara C, Meca-Lallana JE, Gómez-Estévez I, Ara JR, Pérez MÁH, Gil JG, Torres AMA, de la Fuente BP, Ramió-Torrentà L, Madueño SE, Gascón-Giménez F, Casanova B, Martínez-Yélamos S, Valcárcel MA, Ginés MLM, Montero YEB, Real AML, González-Quintanilla V, de Silanes CL, Martínez-Rodríguez JE, Costa-Frossard L, Redondo MG, Fontcuberta AL, Castellanos-Pinedo F, Merino JAG, Fernández CM, Castillo-Triviño T, Meca-Lallana V, Martínez JP, Rodríguez-Antigüedad A, González JMP, Morales EA, Molina IP, Sánchez DMS, Varo NH, Vázquez MA, Barrios JMR, Río J. +37 moreeuropepmc +1 more sourceBeyond lines of treatment: embracing early high-efficacy disease-modifying treatments for multiple sclerosis management. [PDF]
Ther Adv Neurol DisordOreja-Guevara C, Martínez-Yélamos S, Eichau S, Llaneza MÁ, Martín-Martínez J, Peña-Martínez J, Meca-Lallana V, Alonso-Torres AM, Moral-Torres E, Río J, Calles C, Ares-Luque A, Ramió-Torrentà L, Marzo-Sola ME, Prieto JM, Martínez-Ginés ML, Arroyo R, Otano-Martínez MÁ, Brieva-Ruiz L, Gómez-Gutiérrez M, Rodríguez-Antigüedad A, Galán Sánchez-Seco V, Costa-Frossard L, Hernández-Pérez MÁ, Landete-Pascual L, González-Platas M, Meca-Lallana JE. +26 moreeuropepmc +1 more sourceHeterogeneity of cognitive progression and clinical predictors in Parkinson's disease-subjective cognitive decline. [PDF]
J NeurolRodríguez-Antigüedad J, Martínez-Horta S, Puig-Davi A, Horta-Barba A, Pagonabarraga J, de Deus Fonticoba T, Jesús S, Cosgaya M, García Caldentey J, Ávila-Rivera MA, Caballol N, Legarda I, Hernández Vara J, Cabo I, López Manzanares L, González Aramburu I, Gómez Mayordomo V, González Ardura J, Dotor García-Soto J, Borrué C, Solano Vila B, Álvarez Sauco M, Vela L, Escalante S, Cubo E, Mendoza Z, Pareés I, Sánchez Alonso P, Alonso Losada MG, López Ariztegui N, Gastón I, Ruíz Martínez J, Buongiorno MT, Ordás C, Valero C, Puente V, Kurtis M, Blázquez Estrada M, Martínez-Martín P, Mir P, Santos-García D, COPPADIS Study Group, Kulisevsky J. +42 moreeuropepmc +1 more source